Browsing by Subject "awareness"

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Daily Situational Brief, December 3, 2014
    (MESH Coalition, 12/03/14) MESH Coalition
  • Thumbnail Image
    Item
    Daily Situational Brief, June 21, 2011
    (MESH Coalition, 6/21/2011) MESH Coalition
  • Thumbnail Image
    Item
    EXAMINING CONSUMER RACE, GENDER, AND AGE DIFFERENCES IN HOPE AND RECOVERY THROUGH NAMI’S IN OUR OWN VOICE PROGRAM
    (Office of the Vice Chancellor for Research, 2012-04-13) Duerson, Charmayne A.; Brennan, Madeline; Salyers, Michelle P.
    The United States mental health system is in the process of transforming mental health care from treating and reducing symptoms to a relatively new focus on education, awareness, and optimal consumer recovery. The Nation-al Alliance on Mental Illness (NAMI) developed the In Our Own Voice (IOOV) program where consumers present their mental illness and recovery stories as a direct educational and indirect anti-stigma tool. The purpose of this study was to examine the impact that NAMI’s IOOV Program has on con-sumer hope and recovery attitudes. Questionnaires were distributed to four NAMI sites throughout the United States and given to consumers (n = 118) both before and after the IOOV program. The Recovery Expectations Scale, an adaptation of the Consumer Optimism Scale, was used to measure con-sumer recovery attitudes. The Snyder State Hope Scale was used to meas-ure state level hope, with agency and pathways subscales. After the inter-vention, we hypothesized that younger consumers, females, and Caucasians would report greater increases in their hope and expectations for recovery. Contrary to hypotheses, overall state-level hope remained the same throughout the program. Examination of gender differences in hope agency reveals trends, in which females decrease and males only slightly increase after viewing the program. Trends towards significance are also indicated in hope pathways, in which African Americans reported decreased pathways and Caucasians reported increased pathways. In addition, recovery expecta-tions, improved overall, with no significant differences in improvement among demographic variables. Implications of these findings and their im-portance for consumer recovery programs are discussed.
  • Thumbnail Image
    Item
    A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine
    (Elsevier, 2016-03) Kasting, Monica L.; Wilson, Shannon; Dixon, Brian E.; Downs, Stephen M.; Kulkarni, Amit; Zimet, Gregory D.; Department of Epidemiology, Richard M. Fairbanks School of Public Health
    The 9-valent Human Papillomavirus (HPV) vaccine, 9vHPV, was licensed in the U.S. in December, 2014. We assessed healthcare provider (HCP) awareness of the newly approved vaccine and identified questions HCPs have about the vaccine. As part of a larger study, we used semi-structured interviews to ask 22 pediatric HCPs about their awareness of 9vHPV, questions they have about the vaccine, and questions they anticipate from patients and parents. Interviews were audio-recorded and transcribed then analyzed using inductive content analysis. Over half were aware of the vaccine but few HCPs claimed to be familiar with it. HCPs indicated several questions with common themes pertaining to efficacy, side effects, and cost. Only half of HCPs believed patients or parents would have questions. The results suggest strategies and areas for health systems and public health organizations to target in order to resolve unmet educational needs among HCPs regarding 9vHPV.